Comvita Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Comvita has a total shareholder equity of NZ$160.6M and total debt of NZ$87.9M, which brings its debt-to-equity ratio to 54.7%. Its total assets and total liabilities are NZ$307.9M and NZ$147.2M respectively.

Belangrijke informatie

54.7%

Verhouding schuld/eigen vermogen

NZ$87.86m

Schuld

Rente dekkingsratio	n/a
Contant	NZ$8.16m
Aandelen	NZ$160.63m
Totaal verplichtingen	NZ$147.23m
Totaal activa	NZ$307.86m

Recente financiële gezondheidsupdates

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

Mar 21

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Mar 25

Recent updates

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

Mar 21

Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Feb 05

How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 22

Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?

Nov 25

Analyse van de financiële positie

Kortlopende schulden: CVT's short term assets (NZ$192.9M) exceed its short term liabilities (NZ$130.5M).

Langlopende schulden: CVT's short term assets (NZ$192.9M) exceed its long term liabilities (NZ$16.7M).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: CVT's net debt to equity ratio (49.6%) is considered high.

Schuld verminderen: CVT's debt to equity ratio has reduced from 57.3% to 54.7% over the past 5 years.

Schuldendekking: CVT's debt is not well covered by operating cash flow (6.1%).

Rentedekking: Insufficient data to determine if CVT's interest payments on its debt are well covered by EBIT.

Comvita Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Recent updates

Comvita Limited, Annual General Meeting, Oct 30, 2024

New major risk - Financial position

Consensus EPS estimates have been downgraded.

Full year 2024 earnings released: NZ$1.10 loss per share (vs NZ$0.16 profit in FY 2023)

Now 30% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 18%

Upcoming dividend of NZ$0.012 per share

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

First half 2024 earnings released: NZ$0.046 loss per share (vs NZ$0.06 profit in 1H 2023)

Investor sentiment improves as stock rises 21%

Now 28% overvalued

Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Consensus EPS estimates fall by 46%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 56%

Price target decreased by 24% to NZ$3.35

A Look At The Fair Value Of Comvita Limited (NZSE:CVT)

Comvita Limited (NZSE:CVT) acquired an additional 12% stake in Apiter Laboratories for $2 million.

Less than half of directors are independent

Comvita Limited Approves the Appointment of Michael Sang as Director

Upcoming dividend of NZ$0.035 per share at 1.7% yield

Key Executive recently sold NZ$379k worth of stock

Consensus EPS estimates fall by 18%

New minor risk - Earnings quality

Comvita Limited Announces Final Fully Imputed Dividend for the Full Year 2023

Full year 2023 earnings: EPS misses analyst expectations

Comvita Limited, Annual General Meeting, Oct 04, 2023

Investor sentiment improves as stock rises 16%

CEO, MD & Director recently sold NZ$86k worth of stock

Upcoming dividend of NZ$0.029 per share at 1.9% yield

Independent Director recently sold NZ$101k worth of stock

Consensus EPS estimates fall by 15%

First half 2023 earnings released: EPS: NZ$0.06 (vs NZ$0.05 in 1H 2022)

Price target increased to NZ$4.50

High number of new directors

Upcoming dividend of NZ$0.035 per share

High number of new directors

Price target increased to NZ$4.50

Comvita Limited Provides Earnings Guidance for the Year 2023

Comvita Limited, Annual General Meeting, Sep 29, 2022

Insider recently bought NZ$63k worth of stock

Upcoming dividend of NZ$0.029 per share

First half 2022 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of NZ$0.047 per share

Price target increased to NZ$3.70

Full year 2021 earnings released: EPS NZ$0.14 (vs NZ$0.19 loss in FY 2020)

Consensus forecasts updated

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Comvita Launches Special Reserve Manuka and OneHive Movement

We Think Comvita's (NZSE:CVT) Robust Earnings Are Conservative

Is It Too Late To Consider Buying Comvita Limited (NZSE:CVT)?

First half 2021 earnings released: EPS NZ$0.05 (vs NZ$0.26 loss in 1H 2020)

Have Insiders Been Buying Comvita Limited (NZSE:CVT) Shares This Year?

How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?

New 90-day high: NZ$3.40

Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?

Full year earnings released - NZ$0.19 loss per share

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven